Home OLD – Infensa

"Our belief is that any victim of heart attack or stroke anywhere in
the world should have access to therapies that will help them
enjoy a better post-incident quality of life"

Saving hearts and minds

Infensa Bioscience

At Infensa we are committed to bringing the promise of peptide therapy to life for patients suffering a heart attack or stroke

Funnel-web Spider

Infensa is based on a remarkable peptide (Hi1a) from venom of an Australian funnel-web spider that protects brain nerve cells and heart muscle cells from oxygen deprivation

Protects Brain

Hi1a protects the brain from stroke-induced injury even when delivered 8 hours after stroke onset

Protects Heart

Hi1a protects hearts from the injury suffered during a heart attack, and helps preserve donor hearts for transplantation

Game-changing Drugs

Infensa is uniquely placed to develop game-changing drugs for cardiovascular disorders that kill 15 million people a year

Saving hearts and minds

An overview of the opportunity

First-in-class drugs with addressable worldwide market of tens of millions of patients per year
Ability of a single drug class to address multiple diseases enables staged clinical development with continuous value creation: initial focus on heart transplant (low cost) followed by heart attack and stroke (higher cost, massive markets)
Other potential indications: traumatic head injury, hypoxic brain injury (cerebral palsy) retinal artery thrombosis, kidney artery thrombosis, cardiac and brain surgery, endarterectomy, heart valve replacement
Key asset protected by patents granted in USA, EU, Japan, and Australia
Outstanding executive team with more than a century combined experience in biotech sector

What Our Patient Say

Saving hearts and minds

Elsa Minor

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

Elsa Minor